163 related articles for article (PubMed ID: 20165696)
1. Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study.
Blankenberg FG; Levashova Z; Sarkar SK; Pizzonia J; Backer MV; Backer JM
Transl Oncol; 2010 Feb; 3(1):56-64. PubMed ID: 20165696
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of changes in the prevalence of vascular endothelial growth factor receptor in sunitinib-treated murine mammary tumors.
Levashova Z; Backer M; Hamby CV; Pizzonia J; Backer JM; Blankenberg FG
J Nucl Med; 2010 Jun; 51(6):959-66. PubMed ID: 20484434
[TBL] [Abstract][Full Text] [Related]
3. Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF.
Levashova Z; Backer M; Backer JM; Blankenberg FG
J Nucl Med; 2009 Dec; 50(12):2058-63. PubMed ID: 19910439
[TBL] [Abstract][Full Text] [Related]
4. Imaging VEGF Receptors and α
Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL
Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324
[TBL] [Abstract][Full Text] [Related]
5. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE
Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM
Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362
[TBL] [Abstract][Full Text] [Related]
6. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.
Lacal PM; Graziani G
Pharmacol Res; 2018 Oct; 136():97-107. PubMed ID: 30170190
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy.
Takahashi S
Biol Pharm Bull; 2011; 34(12):1785-8. PubMed ID: 22130231
[TBL] [Abstract][Full Text] [Related]
9. Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy.
Rusckowski M; Wang Y; Blankenberg FG; Levashova Z; Backer MV; Backer JM
EJNMMI Res; 2016 Dec; 6(1):4. PubMed ID: 26780081
[TBL] [Abstract][Full Text] [Related]
10. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
[TBL] [Abstract][Full Text] [Related]
11.
Rezazadeh F; Sadeghzadeh N; Abedi SM; Abediankenari S
Nucl Med Biol; 2018; 62-63():54-62. PubMed ID: 29885559
[TBL] [Abstract][Full Text] [Related]
12. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.
Li MY; Lv YC; Tong LJ; Peng T; Qu R; Zhang T; Sun YM; Chen Y; Wei LX; Geng MY; Duan WH; Xie H; Ding J
Acta Pharmacol Sin; 2016 Mar; 37(3):398-407. PubMed ID: 26806300
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici CS; Boşca AB; Şuşman S; Mărginean M; Mihu C; Istrate M; Moldovan IM; Roman AL; Mihu CM
Rom J Morphol Embryol; 2018; 59(2):455-467. PubMed ID: 30173249
[TBL] [Abstract][Full Text] [Related]
14. Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.
Brave SR; Ratcliffe K; Wilson Z; James NH; Ashton S; Wainwright A; Kendrew J; Dudley P; Broadbent N; Sproat G; Taylor S; Barnes C; Silva JC; Farnsworth CL; Hennequin L; Ogilvie DJ; Jürgensmeier JM; Shibuya M; Wedge SR; Barry ST
Mol Cancer Ther; 2011 May; 10(5):861-73. PubMed ID: 21441409
[TBL] [Abstract][Full Text] [Related]
15. Imaging VEGF receptor expression to identify accelerated atherosclerosis.
Tekabe Y; Kollaros M; Zerihoun A; Zhang G; Backer MV; Backer JM; Johnson LL
EJNMMI Res; 2014 Dec; 4(1):41. PubMed ID: 26055940
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
